Julia A. Makarova , Maxim U. Shkurnikov , Daniel Wicklein , Tobias Lange , Timur R. Samatov , Andrey A. Turchinovich , Alexander G. Tonevitsky
{"title":"Intracellular and extracellular microRNA: An update on localization and biological role","authors":"Julia A. Makarova , Maxim U. Shkurnikov , Daniel Wicklein , Tobias Lange , Timur R. Samatov , Andrey A. Turchinovich , Alexander G. Tonevitsky","doi":"10.1016/j.proghi.2016.06.001","DOIUrl":"10.1016/j.proghi.2016.06.001","url":null,"abstract":"<div><p>MicroRNA (miRNA) is a class of small non-coding RNAs which mediate post-transcriptional gene silencing (PTGS) by sequence-specific inhibition of target mRNAs translation and/or lowering their half-lives in the cytoplasm. Together with their binding partners, Argonaute (AGO) proteins, miRNAs form cores of RNA-induced silencing complexes (RISC). Despite a substantial progress in understanding RISC structure, until recently little was known about its localization in the cell. This review is aimed to provide an overview of the emerging picture of miRNA and RISC localization and function both in the intracellular space and outside of the cell. In contrast to the common assumption that PTGS occurs in the cytoplasm, it was found to operate mainly on the membranes of the endoplasmic reticulum (ER). Besides ER membranes miRNAs were found in all main cellular compartments including nucleus, nucleolus and mitochondria where they regulate various processes including transcription, translation, alternative splicing and DNA repair. Moreover, a certain pool of miRNAs may not be associated with RISC and carry completely different functions. Finally, the discovery of cell-free miRNAs in all biological fluids suggests that miRNAs might also act as signaling molecules outside the cell, and may be utilized as biomarkers for a variety of diseases. In this review we discuss miRNA secretion mechanisms and possible pathways of cell-cell communication <em>via</em> miRNA-containing exosomes <em>in vivo</em>.</p></div>","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 3","pages":"Pages 33-49"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.proghi.2016.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34654044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xingde Liu , Yiming Wang , Wenxiu Yang , Zhizhong Guan , Wenfeng Yu , D.Joshua Liao
{"title":"Protein multiplicity can lead to misconduct in western blotting and misinterpretation of immunohistochemical staining results, creating much conflicting data","authors":"Xingde Liu , Yiming Wang , Wenxiu Yang , Zhizhong Guan , Wenfeng Yu , D.Joshua Liao","doi":"10.1016/j.proghi.2016.11.001","DOIUrl":"10.1016/j.proghi.2016.11.001","url":null,"abstract":"<div><p>Western blotting (WB) and immunohistochemical staining (IHC) are common techniques for determining tissue protein expression. Both techniques require a primary antibody specific for the protein in question. WB data is band(s) on a membrane while IHC result is a staining on a tissue section. Most human genes are known to produce multiple protein isoforms; in agreement with that, multiple bands are often found on the WB membrane. However, a common but unspoken practice in WB is to cut away the extra band(s) and present for publication only the band of interest, which implies to the readers that only one form of protein is expressed and thus the data interpretation is straightforward. Similarly, few IHC studies discuss whether the antibody used is isoform-specific and whether the positive staining is derived from only one isoform. Currently, there is no reliable technique to determine the isoform-specificity of an antibody, especially for IHC. Therefore, cutting away extra band(s) on the membrane usually is a form of misconduct in WB, and a positive staining in IHC only indicates the presence of protein product(s) of the to-be-interrogated gene, and not necessarily the presence of the isoform of interest. We suggest that data of WB and IHC involving only one antibody should not be published and that relevant reports should discuss whether there may be protein multiplicity and whether the antibody used is isoform-specific. Hopefully, techniques will soon emerge that allow determination of not only the presence of protein products of genes but also the isoforms expressed.</p></div>","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 3","pages":"Pages 51-58"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.proghi.2016.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"55032935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ifc Editorial Board","authors":"","doi":"10.1016/S0079-6336(16)30056-0","DOIUrl":"https://doi.org/10.1016/S0079-6336(16)30056-0","url":null,"abstract":"","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 3","pages":"Page IFC"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6336(16)30056-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137157106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adriano Azaripour , Tonny Lagerweij , Christina Scharfbillig , Anna Elisabeth Jadczak , Brita Willershausen , Cornelis J.F. Van Noorden
{"title":"A survey of clearing techniques for 3D imaging of tissues with special reference to connective tissue","authors":"Adriano Azaripour , Tonny Lagerweij , Christina Scharfbillig , Anna Elisabeth Jadczak , Brita Willershausen , Cornelis J.F. Van Noorden","doi":"10.1016/j.proghi.2016.04.001","DOIUrl":"10.1016/j.proghi.2016.04.001","url":null,"abstract":"<div><p>For 3-dimensional (3D) imaging of a tissue, 3 methodological steps are essential and their successful application depends on specific characteristics of the type of tissue. The steps are 1° clearing of the opaque tissue to render it transparent for microscopy, 2° fluorescence labeling of the tissues and 3° 3D imaging. In the past decades, new methodologies were introduced for the clearing steps with their specific advantages and disadvantages. Most clearing techniques have been applied to the central nervous system and other organs that contain relatively low amounts of connective tissue including extracellular matrix. However, tissues that contain large amounts of extracellular matrix such as dermis in skin or gingiva are difficult to clear. The present survey lists methodologies that are available for clearing of tissues for 3D imaging. We report here that the BABB method using a mixture of benzyl alcohol and benzyl benzoate and iDISCO using dibenzylether (DBE) are the most successful methods for clearing connective tissue-rich gingiva and dermis of skin for 3D histochemistry and imaging of fluorescence using light-sheet microscopy.</p></div>","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 2","pages":"Pages 9-23"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.proghi.2016.04.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34452781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Timur R. Samatov , Daniel Wicklein , Alexander G. Tonevitsky
{"title":"L1CAM: Cell adhesion and more","authors":"Timur R. Samatov , Daniel Wicklein , Alexander G. Tonevitsky","doi":"10.1016/j.proghi.2016.05.001","DOIUrl":"10.1016/j.proghi.2016.05.001","url":null,"abstract":"<div><p>L1CAM is a cell adhesion molecule of the immunoglobulin superfamily which was originally discovered as a major player in the development of the nervous system. L1CAM was demonstrated to have prognostic value in different cancers and to be a promising target for anti-cancer therapy. Here we overview the present data on L1CAM structure and function, regulation of its expression, role in cancer and therapeutic potential.</p></div>","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 2","pages":"Pages 25-32"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.proghi.2016.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34550202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ifc Editorial Board","authors":"","doi":"10.1016/S0079-6336(16)30043-2","DOIUrl":"https://doi.org/10.1016/S0079-6336(16)30043-2","url":null,"abstract":"","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 2","pages":"Page IFC"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6336(16)30043-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137286455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A.S.M. Hung , Y. Liang , Tony C.H. Chow , H.C. Tang , Sharon L.Y. Wu , M.S.M. Wai , D.T. Yew
{"title":"Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review","authors":"A.S.M. Hung , Y. Liang , Tony C.H. Chow , H.C. Tang , Sharon L.Y. Wu , M.S.M. Wai , D.T. Yew","doi":"10.1016/j.proghi.2016.01.001","DOIUrl":"10.1016/j.proghi.2016.01.001","url":null,"abstract":"<div><p>This review discussed the importance of mutated tau, amyloid and neuroinflammatory factors and microglia in Alzheimer disease. In particular tau, CD4 and TNF alpha were included in the review and the colocalizations of these factors were highlighted. It is important to realize the Alzheimer disease may result from the interactions of these factors. Some of these factors may coexist at the same region and at the same time e.g. mutated tau and amyloid in plaques. A summary scheme of etiology leading to the disease was included.</p></div>","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 1","pages":"Pages 1-8"},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.proghi.2016.01.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"55032921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ifc Editorial Board","authors":"","doi":"10.1016/S0079-6336(16)30009-2","DOIUrl":"https://doi.org/10.1016/S0079-6336(16)30009-2","url":null,"abstract":"","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"51 1","pages":"Page IFC"},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6336(16)30009-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137347567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ifc Editorial Board","authors":"","doi":"10.1016/S0079-6336(16)00011-5","DOIUrl":"https://doi.org/10.1016/S0079-6336(16)00011-5","url":null,"abstract":"","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"50 4","pages":"Page IFC"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0079-6336(16)00011-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137340514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In situ hybridisation: Technologies and their application to understanding disease","authors":"Anthony Warford","doi":"10.1016/j.proghi.2015.12.001","DOIUrl":"10.1016/j.proghi.2015.12.001","url":null,"abstract":"<div><p>In situ hybridisation (ISH) is unique amongst molecular analysis methods in providing for the precise microscopic localisation of genes, mRNA and microRNA in metaphase spreads, cell and tissue preparations. The method is well established as a tool to guide appropriate therapeutic intervention in breast, gastric and lung cancer. With the description of ultrasensitive ISH technologies for low copy mRNA demonstration and the relative ease by which microRNA can be visualised, the applications for research and diagnostic purposes is set to increase dramatically. In this review ISH is considered with emphasis on recent technological developments and surveyed for present and future applications in the context of the demonstration of genes, mRNA and microRNA in health and disease.</p></div>","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"50 4","pages":"Pages 37-48"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.proghi.2015.12.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"55032908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}